Global Halal Pharmaceuticals Market Expected to Hit USD 34.82 Billion by 2026
7 Nov, 2024
The Halal Pharmaceuticals Market has witnessed significant growth in recent years, Our comprehensive research report titled Halal Pharmaceuticals market offers a thorough analysis of the current market landscape and sheds light on the market trends, competitive dynamics, and growth opportunities. Also, it identifies the top players in the market and assesses their offerings, strategies, market share, and performance to help stakeholders make informed decisions and stay ahead of the competition.
Market Overview:
According to the research report published by Polaris Market Research, the Global Halal Pharmaceuticals Market Is Anticipated To Reach USD 34.82 Billion By 2026, at a CAGR of 5.7% during the forecast period.
Research Methodology:
Our research methodology combines qualitative and quantitative methods to offer a thorough analysis of the market. These research techniques used include:
Focus Groups: Includes qualitative data and insights into customer attitudes and opinions.
Surveys: Offers insights into consumer behavior, opinion, and interests.
Interviews: The study covers in-depth conversations with individuals to collect information about attitudes, beliefs, and motivations.
Secondary Research: The report analyzes existing data from reports, publications, and other credible sources.
All the information in the Halal Pharmaceuticals market research report goes through a multi-step verification method to ensure its accuracy and reliability.
List of Market Key Players:
The market has the presence of both established players and new entrants. These players are focusing on innovation and strategic partnerships to expand their global reach and increase their Halal Pharmaceuticals market share. Some of the key players in the market are:
Chemical Company of Malaysia Berhad
Rosemont Pharmaceuticals
Bosch Pharmaceuticals
Noor Vitamins
EMBIL Pharmaceutical Co. Ltd
Nutramedica Incorporated
PharmaniagaBhd
SimporPharmaSdnBhd
Overview of Top Companies:
Chemical Company of Malaysia Berhad (CCM)
Established in 1930, Chemical Company of Malaysia Berhad (CCM) is a leading chemicals company in Malaysia with over 50 years of expertise in the industry. The company's core strengths lie in specialty chemicals and polymers, focusing on delivering innovative solutions to enhance the quality of life.
CCM's operations are structured into two main business segments:
Chemicals: This segment specializes in the manufacture and marketing of chlor-alkali and coagulant products, industrial and specialty chemicals, and polymer coatings.
Polymers: This segment focuses on producing industrial cleaners and hydrogel coating products.
In December 2020, Batu Kawan Berhad completed the acquisition of the remaining 43.7% stake in CCM, making it a wholly-owned subsidiary.
Rosemont Pharmaceuticals
Founded in 1967 and headquartered in Leeds, UK, Rosemont Pharmaceuticals is a specialty pharmaceutical company dedicated to developing, manufacturing, and supplying oral liquid medicines, particularly for patients with swallowing difficulties. The company offers a portfolio of over 130 oral liquid medicines across various therapeutic areas.
In June 2020, Inflexion Private Equity Partners acquired Rosemont Pharmaceuticals from Perrigo Company plc for £156 million, aiming to support Rosemont's growth and innovation in liquid medicines.
Rosemont has been actively expanding its product portfolio and international presence. In July 2024, the company acquired Lucis Pharma Ltd, a UK-based specialist pharmaceutical business, to enter the single-use sachet pharmaceutical market.
Additionally, in June 2024, Rosemont acquired Pharma-Data, a research and development organization based in Lavrion, Greece, to enhance its global product development capabilities.
Both CCM and Rosemont Pharmaceuticals continue to innovate and expand their offerings to meet the evolving needs of their respective markets.
Browse More Information:
Competitive Landscape:
The competitive landscape of the market is shaped by strategic partnerships and collaborations among Halal Pharmaceuticals market key players. These strategic initiatives are aimed at expanding their product portfolios and expanding their global reach. Companies like Chemical Company of Malaysia Berhad, Rosemont Pharmaceuticals, Bosch Pharmaceuticals, Noor Vitamins, EMBIL Pharmaceutical Co. Ltd, Nutramedica Incorporated, PharmaniagaBhd, SimporPharmaSdnBhd are leveraging their global reach to cater to diverse consumer needs across various regions. Other players, such as Chemical Company of Malaysia Berhad, Rosemont Pharmaceuticals, Bosch Pharmaceuticals, Noor Vitamins, EMBIL Pharmaceutical Co. Ltd, are focusing on the incorporation of advanced technologies to improve their offerings. As the market evolves, the competition is set to intensify in the upcoming years.
Conclusion:
The Halal Pharmaceuticals market growth is poised to continue in the upcoming years, Companies adapting to shifting consumer preferences and technological innovations will continue to thrive in the evolving market landscape.
More Trending Latest Reports By Polaris Market Research:
Write a comment ...